CEL-SCI Announces Proposed Public Offering Of Common Stock And Warrants
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM), a late-stage oncology company, today announced that it intends to offer and sell common stock and warrants in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed.
Help employers find you! Check out all the jobs and post your resume.